Health Net
Kanjinti (trastuzumab-anns)
Drugs for Cancer : Drugs for Cancer
  • Preventive Drug: Zero copay.
  • Chemo-induced Nausea and Vomiting (CINV):
    Age Requirement: >= 18
    Duration: 3 Day(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: >= 3 day(s)
    NV associated with highly emetogenic cancer chemotherapy (HEC): No
    NV associated with moderately emetogenic cancer chemotherapy (MEC): No
    Concomitant therapy with Corticosteroid: No
    Concomitant therapy with 5-HT3 Antagonist: No

  • Quantity Limit: 204 lancets per 30 day(s).